- Home
- IPHA vs FNWD Comparison
IPHA vs FNWD Comparison
Compare IPHA & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- FNWD
- Stock Information
- Founded
- IPHA 1999
- FNWD 1994
- Country
- IPHA France
- FNWD United States
- Employees
- IPHA N/A
- FNWD N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- FNWD Savings Institutions
- Sector
- IPHA Health Care
- FNWD Finance
- Exchange
- IPHA Nasdaq
- FNWD Nasdaq
- Market Cap
- IPHA 160.1M
- FNWD 143.6M
- IPO Year
- IPHA 2019
- FNWD N/A
- Fundamental
- Price
- IPHA $1.82
- FNWD $35.98
- Analyst Decision
- IPHA Strong Buy
- FNWD Buy
- Analyst Count
- IPHA 3
- FNWD 1
- Target Price
- IPHA $5.00
- FNWD $34.00
- AVG Volume (30 Days)
- IPHA 572.8K
- FNWD 32.6K
- Earning Date
- IPHA 09-17-2025
- FNWD 10-28-2025
- Dividend Yield
- IPHA N/A
- FNWD 1.33%
- EPS Growth
- IPHA N/A
- FNWD N/A
- EPS
- IPHA N/A
- FNWD 1.91
- Revenue
- IPHA $14,839,695.00
- FNWD $66,563,999.00
- Revenue This Year
- IPHA $22.29
- FNWD N/A
- Revenue Next Year
- IPHA $43.84
- FNWD $8.42
- P/E Ratio
- IPHA N/A
- FNWD $18.74
- Revenue Growth
- IPHA N/A
- FNWD N/A
- 52 Week Low
- IPHA $1.41
- FNWD $26.12
- 52 Week High
- IPHA $3.51
- FNWD $36.41
- Technical
- Relative Strength Index (RSI)
- IPHA 42.84
- FNWD 70.27
- Support Level
- IPHA $1.73
- FNWD $35.00
- Resistance Level
- IPHA $1.86
- FNWD $36.41
- Average True Range (ATR)
- IPHA 0.12
- FNWD 1.19
- MACD
- IPHA -0.02
- FNWD 0.17
- Stochastic Oscillator
- IPHA 11.51
- FNWD 99.26
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.